SCNN1B and neoplasm: The anti-tumor effect of SCNN1B is mediated via degradation of the endoplasmic reticulum chaperone GRP78, which is frequently up-regulated during cancer progression to counter unfolded protein response (UPR), maintain ER homeostasis and promote cell survival [13].